Ebola Vaccine Considered to be Safe

The experimental Ebola vaccine has been found to be safe in preliminary results from a clinical trial. The Ebola vaccine has been developed by GlaxoSmithKline and the UN National Institutes for Health. Researchers confirmed the safety of the vaccine on Wednesday. The vaccine also generates an immune response to Ebola, said the early findings from the trial under way at Oxford University, and published in the New England Journal of Medicine. "The vaccine ...